Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, quadruple-blind study.

ABSTRACT:

Background and aim

Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, called Kan Jang®, are traditionally used for relieving symptoms of upper-respiratory tract infections (URTIs). This study aimed to assess the efficacy of early intervention with Kan Jang® on the relief and duration of inflammatory symptoms during the acute phase of the disease.

Experimental procedure

A total of 179 patients with URTI symptoms received six Kan Jang® (daily dose of andrographolides: 60 mg) or placebo capsules a day for five consecutive days in this randomized, quadruple-blinded, placebo-controlled, two-parallel-group phase II study. The primary efficacy outcomes were the decrease in the acute-phase duration and the mean URTI symptom

SUBMITTER: Narimanyan M 

PROVIDER: S-EPMC8572720 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature